Abstract:
A device, system and method for enhancing the functionality and efficiency of a chemical and/or enzymatic debriding agent with a physical debriding mechanism. The debriding agent alone and the physical mechanism alone are each capable of at least some debriding activity separately, without being used in the combination. In combination, however, they are more effective, such that the debriding efficacy is increased for the combination. Preferably, the physical debriding mechanism comprises an ultrasound source.
Abstract:
A method of harvesting a tissue sample (318) from a subject (311), comprising: attaching an outer surface of a portion of the tissue sample (318) to a substantially flat surface area; lifting the surface area, together with the portion of the tissue (318); and slicing the tissue (318) at a given distance below the surface area of said portion to separate the portion to separate the tissue portion (318) from the subject (311).
Abstract:
Method of holding in place a transcutaneous implant by applying an adhesive in liquid form to the implant and the area of the patient's skin about the needle and allowing the adhesive to set. The implant is constituted by an infusion needle, a catheter or any transcutaneous implant. Whenever the adhesive is in liquid form, it has such a surface tension that it will flow along the implant and the skin to reach a terminal point, which is the point at which the implant is inserted. The adhesive is applied in liquid form and flows along the implant and the skin to reach the point at which the implant is inserted, and then allowed to set, to hold the implant in place.
Abstract:
The present invention relates to a proteolytic extract obtained from bromelain for the treatment of connective tissue diseases. In particular, the present invention relates to a pharmaceutical composition comprising a proteolytic extract obtained from bromelain for the treatment of diseases such as Dupuytren's disease and Peyronie's disease.
Abstract:
The present invention discloses a safe surgical mouth gag (MG) (30) comprising a substantially planar frame larger than the maximal mouth aperture which is defined by at least two cross members, i.e., a longitudinal maxillary cross member (33) and a mandibular cross member (32) and by at least one rod (29) connecting said maxillary and said mandibular cross members; and modules maneuverably interconnected to the same. Said modules are selected from a tongue blade (50) approximately perpendicular to said frames' plane, which is vertically displaceable with respect to said mandibular cross member; a retaining member (53) within which said tongue blade shaft is slidably displaceable; retraction elements (35) for urging the cheeks away from the oral cavity; abutment members (40) for contacting the upper teeth or upper maxilla; and at least one light auxiliary (101) located adjacent to oral cavity, adapted to illuminate the same effectively.
Abstract:
The invention relates to compositions for debriding damaged skin comprising at least one enzymatic debriding agent and at least one antiseptic compound comprising heavy metal ions. The present invention further relates to kit and methods for topical debridement of damaged skin, particularly of burned skin.
Abstract:
A device (10), system and method for enhancing the functionality and efficiency of a chemical and/or enzymatic debriding agent with a physical debriding mechanism includes a container (11) which is optionallz implemented as a round cup and features an acoustic chamber (12) with an ultrasound source (18) at the top of the acoustic chamber (12).
Abstract:
Embodiments of the present invention provide Dermal Micro Organs (DMOs), methods and apparatuses for producing the same. Some embodiments of the invention provide a DMO including a plurality of dermal components, which substantially retain the micro-architecture and three dimensional structure of the dermal tissue from which they are derived, having dimensions selected so as to allow passive diffusion of adequate nutrients and gases to cells of the DMO and diffusion of cellular waste out of the cells so as to minimize cellular toxicity and concomitant death due to insufficient nutrition and accumulation of waste in the DMO. Some embodiments of the invention provide methods and apparatuses for harvesting the DMO. An apparatus for harvesting the DMO may include, according to some exemplary embodiments, a support configuration to support a skin-related tissue structure from which the DMO is to be harvested, and a cutting tool able to separate the DMO from the skin-related tissue structure. Other embodiments are described and claimed.
Abstract:
The present invention relates to a device and methods suitable for use in the prevention and treatment of burn induced compartment syndrome, and to specifically designed applications means for the rapid and efficient deployment of enzymatic compositions to the affected limb or limbs of a burn victim suffering from a circumferential burn, as well as to methods of using these enzymatic compositions in conjunction with the applications means.
Abstract:
The present invention discloses a safe surgical mouth gag (MG) (30) comprising a substantially planar frame larger than the maximal mouth aperture which is defined by at least two cross members, i.e., a longitudinal maxillary cross member (33) and a mandibular cross member (32) and by at least one rod (29) connecting said maxillary and said mandibular cross members; and modules maneuverably interconnected to the same. Said modules are selected from a tongue blade (50) approximately perpendicular to said frames' plane, which is vertically displaceable with respect to said mandibular cross member; a retaining member (53) within which said tongue blade shaft is slidably displaceable; retraction elements (35) for urging the cheeks away from the oral cavity; abutment members (40) for contacting the upper teeth or upper maxilla; and at least one light auxiliary (101) located adjacent to oral cavity, adapted to illuminate the same effectively.